International Biotechnology Trust plc - IBT
Investing in biotechnology for a healthier futureAccess the fast-growing biotechnology sector through an actively managed, diversified investment trust
International Biotechnology Trust (IBT) offers investors access to one of the most dynamic sectors in global markets, managed by a specialist team with a proven record of identifying innovative companies at the forefront of medical science.
Structural growth and differentiating income
Older, wealthier, healthier – three demographic megatrends driving sustained demand for better healthcare solutions, making biotechnology one of the most compelling structural growth opportunities in global markets. IBT also offers a dividend equivalent to 4% of net asset value each year.
Where innovation meets opportunity
The managers seek out well-managed businesses with a clear path to realising their commercial potential, including select exposure to unquoted opportunities. The team has a strong record of identifying bid targets – though its core holdings are equally capable of delivering significant value as independent businesses.
Thirty years of specialist expertise
IBT was established in 1994, making it the longest-standing trust in the biotech and healthcare AIC sector. Ailsa Craig and Marek Poszepczynski bring decades of experience and have delivered an enviable track record since becoming lead portfolio managers in 2021, combining rigorous stock selection with disciplined risk management.
Portfolio Company Updates
Download Key Material
Portfolio & Performance Hub
Source: Morningstar, February 2026
Source: Association of Investment Companies, 2026
Source: Citywire, 2026
Source: Kepler Trust Intelligence, 2026
In the Media
Documents
Invest in the International Biotechnology Trust plc (IBT)
It is easy to make regular, tax-efficient investments into investment trust shares with a UK online stockbroker. We recommend you seek financial advice from an independent adviser before making an investment decision.